6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-2(1H)-quinolinone;OPC 13015; USP Cilostazol Related Compound B
Cilostazol Metabolite (OPC-13015) is a fully characterized chemical compound used as a reference standard of API Cilostazol. The standard offered is compliant with regulatory guidelines. Cilostazol Metabolite (OPC-13015) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 73963-62-9
